20,000 Shares in Koninklijke Philips N.V. $PHG Bought by Corient IA LLC

Key Points

• Corient IA LLC has invested approximately $508,000 in Koninklijke Philips N.V. by purchasing 20,000 shares during the first quarter.
• Multiple institutional investors have significantly increased their holdings in Koninklijke Philips, with Colonial Trust Co SC raising its position by 724.0% during the fourth quarter.
• The company reported an EPS of $0.41 for its last quarter, exceeding analysts' expectations of $0.29, with revenues hitting $5.05 billion.

Corient IA LLC bought a new position in shares of Koninklijke Philips N.V. (NYSE:PHG - Free Report) during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 20,000 shares of the technology company's stock, valued at approximately $508,000.

Several other institutional investors and hedge funds have also made changes to their positions in PHG. Wells Fargo & Company MN boosted its holdings in shares of Koninklijke Philips by 7.2% during the 4th quarter. Wells Fargo & Company MN now owns 271,521 shares of the technology company's stock worth $6,875,000 after purchasing an additional 18,296 shares during the last quarter. Mariner LLC raised its position in shares of Koninklijke Philips by 11.4% during the 4th quarter. Mariner LLC now owns 94,458 shares of the technology company's stock valued at $2,392,000 after buying an additional 9,693 shares during the period. GeoWealth Management LLC raised its position in shares of Koninklijke Philips by 4.5% during the 4th quarter. GeoWealth Management LLC now owns 19,255 shares of the technology company's stock valued at $488,000 after buying an additional 825 shares during the period. Forum Financial Management LP raised its position in shares of Koninklijke Philips by 18.0% during the 4th quarter. Forum Financial Management LP now owns 11,703 shares of the technology company's stock valued at $296,000 after buying an additional 1,784 shares during the period. Finally, First Trust Advisors LP raised its position in shares of Koninklijke Philips by 58.4% during the 4th quarter. First Trust Advisors LP now owns 184,573 shares of the technology company's stock valued at $4,673,000 after buying an additional 68,071 shares during the period. 13.67% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Separately, Wall Street Zen lowered shares of Koninklijke Philips from a "buy" rating to a "hold" rating in a research report on Saturday, August 2nd. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, the stock presently has a consensus rating of "Buy".

Koninklijke Philips Stock Down 1.2%

Shares of NYSE:PHG traded down $0.3350 during trading on Thursday, hitting $27.4250. The company's stock had a trading volume of 498,637 shares, compared to its average volume of 995,413. The business has a 50 day moving average price of $25.03 and a two-hundred day moving average price of $25.01. The company has a market capitalization of $26.41 billion, a PE ratio of 144.34, a P/E/G ratio of 0.75 and a beta of 0.75. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.81 and a current ratio of 1.26. Koninklijke Philips N.V. has a fifty-two week low of $21.48 and a fifty-two week high of $32.91.

Koninklijke Philips (NYSE:PHG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The technology company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.29 by $0.12. The business had revenue of $5.05 billion during the quarter, compared to the consensus estimate of $4.35 billion. Koninklijke Philips had a net margin of 1.00% and a return on equity of 11.95%. As a group, research analysts expect that Koninklijke Philips N.V. will post 1.63 EPS for the current fiscal year.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.